Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 39 Melanoma 34 Gliosarcoma 34 Brain Neoplasms 33 Breast Neoplasms 31 Lymphoma 24 Neoplasm Metastasis 23 Astrocytoma 23 Colonic Neoplasms 20 Multiple Myeloma 19 Leukemia, Myeloid, Acute 19 Leukemia 19 Carcinoma, Non-Small-Cell Lung 19 Prostatic Neoplasms 18 Lymphoma, Non-Hodgkin 18 Colorectal Neoplasms 18 Central Nervous System Neoplasms 18 Carcinoma, Renal Cell 18 Rectal Neoplasms 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Neoplasms 17 Lymphoma, Large B-Cell, Diffuse 17 Leukemia, Lymphocytic, Chronic, B-Cell 16 Hodgkin Disease 16 Squamous Cell Carcinoma of Head and Neck 15 Oligodendroglioma 15 Pancreatic Neoplasms 14 Myelodysplastic Syndromes 14 Lung Neoplasms 14 Sarcoma 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NIH × Malaria × Clear all

NCT00341250 2017-07-02

Malaria Vaccine in Children in Mali

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed

Burkitt Lymphoma, Malaria

Data powered by HemOnc (CC BY 4.0) Colophon ⚡